Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2022 | Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models | Lee M.T.; Mouri A.; Kubota H.; Lee H.-J.; Chang M.-H.; Wu C.-Y.; Knutson D.E.; Mihovilovic M.; Cook J.; Sieghart W.; Nabeshima T.; LIH-CHU CHIOU | Biomedicine and Pharmacotherapy | 7 | 4 | |
2018 | The α6 subunit-containing GABA A receptor: A novel drug target for inhibition of trigeminal activation | PI-CHUAN FAN ; Lai T.-H.; Hor C.C.; Lee M.T.; Huang P.; Sieghart W.; Ernst M.; Knutson D.E.; Cook J.; LIH-CHU CHIOU | Neuropharmacology | 16 | 15 | |
2021 | α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia | Tzeng H.-R.; Lee M.T.; PI-CHUAN FAN ; Knutson D.E.; Lai T.-H.; Sieghart W.; Cook J.; LIH-CHU CHIOU | Neurotherapeutics | 14 | 10 |